The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
The pharmacology of statins
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial
Huijgen, R., Boekholdt, S. M., Arsenault, B. J., Bao, W., Davaine, J., Tabet, F., Petrides, F., Rye, K., DeMicco, D. A., Barter, P. J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.043 · Cited by 56
RetractedOLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
ENDO, A., KURODA, M., & TSUJITA, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816
Statin Safety: A Systematic Review
Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 794
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565
Bilheimer, D. W., Grundy, S. M., Brown, M. S., & Goldstein, J. L. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.4124 · Cited by 557
Brown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I., & Endo, A. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38120-6 · Cited by 556
Parker, R. A., Pearce, B. C., Clark, R. W., Gordon, D. A., & Wright, J. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82115-9 · Cited by 436
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Jaramillo, J. J., & Brown, M. S. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.1194 · Cited by 421
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
Keskitalo, J. E., Zolk, O., Fromm, M. F., Kurkinen, K. J., Neuvonen, P. J., & Niemi, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.79 · Cited by 416
Risk of incident diabetes among patients treated with statins: population based study
Carter, A. A., Gomes, T., Camacho, X., Juurlink, D. N., Shah, B. R., & Mamdani, M. M. (2013) · BMJ · doi:10.1136/bmj.f2610 · Cited by 404
Plenge, J. K., Hernandez, T. L., Weil, K. M., Poirier, P., Grunwald, G. K., Marcovina, S. M., & Eckel, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000029743.68247.31 · Cited by 354
Non-lipid-related effects of statins
Bellosta, S., Fed, N., Bernini, F., Paoletti, R., & Corsini, A. (2000) · Annals of Medicine · doi:10.3109/07853890008998823 · Cited by 333
Bianchi, S., Bigazzi, R., Caiazza, A., & Campese, V. M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50140 · Cited by 332
Jeong, H. J., Lee, H.-S., Kim, K.-S., Kim, Y.-K., Yoon, D., & Park, S. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700443-jlr200 · Cited by 331
Transporter Pharmacogenetics and Statin Toxicity
Niemi, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.197 · Cited by 330
Förstermann, U., & Li, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01196.x · Cited by 300
Chasman, D. I., Giulianini, F., MacFadyen, J., Barratt, B. J., Nyberg, F., & Ridker, P. M. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961144 · Cited by 285
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity
Hanai, J.-I., Cao, P., Tanksale, P., Imamura, S., Koshimizu, E., Zhao, J., Kishi, S., Yamashita, M., Phillips, P. S., Sukhatme, V. P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32741 · Cited by 281
Outcomes in 45 Patients With Statin-Associated Myopathy
Hansen, K. E., Hildebrand, J. P., Ferguson, E. E., & Stein, J. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2671 · Cited by 280
Statin Safety: An Overview and Assessment of the Data—2005
Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264
Corpier, C. L. (1988) · JAMA · doi:10.1001/jama.260.2.239 · Cited by 237
Therapeutic effects of ML-236B in primary hypercholesterolemia
Yamamoto, A., Sudo, H., & Endo, A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90124-0 · Cited by 231
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
Mangravite, L. M., Engelhardt, B. E., Medina, M. W., Smith, J. D., Brown, C. D., Chasman, D. I., Mecham, B. H., Howie, B., Shim, H., Naidoo, D., et al. (2013) · Nature · doi:10.1038/nature12508 · Cited by 224
Sinzinger, H., & O'Grady, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02044.x · Cited by 223
FIEGENBAUM, M., DASILVEIRA, F., VANDERSAND, C., VANDERSAND, L., FERREIRA, M., PIRES, R., & HUTZ, M. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.003 · Cited by 216
DeGorter, M. K., Tirona, R. G., Schwarz, U. I., Choi, Y.-H., Dresser, G. K., Suskin, N., Myers, K., Zou, G., Iwuchukwu, O., Wei, W.-Q., et al. (2013) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000099 · Cited by 195
HMG‐CoA reductase inhibitors and P‐glycoprotein modulation
Bogman, K., Peyer, A., Török, M., Küsters, E., & Drewe, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703920 · Cited by 194
Patti, G., Cannon, C. P., Murphy, S. A., Mega, S., Pasceri, V., Briguori, C., Colombo, A., Yun, K. H., Jeong, M. H., Kim, J.-S., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.002451 · Cited by 188
Pradeep, A. R., & Thorat, M. S. (2010) · Journal of Periodontology · doi:10.1902/jop.2009.090429 · Cited by 185
Unexpected antimicrobial effect of statins
Jerwood, S., & Cohen, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm496 · Cited by 182
Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.242 · Cited by 181
Germershausen, J. I., Hunt, V. M., Bostedor, R. G., Bailey, P. J., Karkas, J. D., & Alberts, A. W. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92773-3 · Cited by 170
Masadeh, M., Mhaidat, N., Alzoubi, K., Al-azzam, S., & Alnasser, Z. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-13 · Cited by 169
Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia
Hubacek, J. A., Berge, K. E., Cohen, J. C., & Hobbs, H. H. (2001) · Human Mutation · doi:10.1002/humu.1206 · Cited by 166
Association between statin-associated myopathy and skeletal muscle damage
Mohaupt, M. G., Karas, R. H., Babiychuk, E. B., Sanchez-Freire, V., Monastyrskaya, K., Iyer, L., Hoppeler, H., Breil, F., & Draeger, A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081785 · Cited by 166
Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia
Draeger, A., Monastyrskaya, K., Mohaupt, M., Hoppeler, H., Savolainen, H., Allemann, C., & Babiychuk, E. (2006) · The Journal of Pathology · doi:10.1002/path.2018 · Cited by 163
Sidaway, J. E., Davidson, R. G., McTaggart, F., Orton, T. C., Scott, R. C., Smith, G. J., & Brunskill, N. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000138236.82706.ee · Cited by 154
Cognitive Impairment Associated with Atorvastatin and Simvastatin
King, D. S., Wilburn, A. J., Wofford, M. R., Harrell, T. K., Lindley, B. J., & Jones, D. W. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1663.31953 · Cited by 152
Carr, D. F., O’Meara, H., Jorgensen, A., Campbell, J., Hobbs, M. R., McCann, G., van Staa, T. P., & Pirmohamed, M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.161 · Cited by 148
Hudgins, L. C., Parker, T. S., Levine, D. M., Gordon, B. R., Saal, S. D., Jiang, X., Seidman, C. E., Tremaroli, J. D., Lai, J., & Rubin, A. L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200440-jlr200 · Cited by 142
Massaro, M., Zampolli, A., Scoditti, E., Carluccio, M. A., Storelli, C., Distante, A., & Caterina, R. D. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp375 · Cited by 134
Meigs, T. E., Roseman, D. S., & Simoni, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.7916 · Cited by 133
KOVANEN, P. T., BASU, S. K., GOLDSTEIN, J. L., & BROWN, M. S. (1979) · Endocrinology · doi:10.1210/endo-104-3-610 · Cited by 131
High-Dose Atorvastatin Reduces Periodontal Inflammation
Subramanian, S. S., Emami, H., Vucic, E., Singh, P., Vijayakumar, J., Fifer, K. M., Alon, A., Shankar, S. S., Farkouh, M. E., Rudd, J. H. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1627 · Cited by 130
Puri, R., Nissen, S. E., Libby, P., Shao, M., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Raichlen, J. S., Uno, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004243 · Cited by 124
Miettinen, T. A., Gylling, H., & Nissinen, M. J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.05.005 · Cited by 105
Association of Statin Use With Cataracts
Leuschen, J., Mortensen, E. M., Frei, C. R., Mansi, E. A., Panday, V. A., & Mansi, I. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4575 · Cited by 102
Baetta, R., Camera, M., Comparato, C., Altana, C., Ezekowitz, M. D., & Tremoli, E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012802.69414.a8 · Cited by 100
Inhibition of in vitro cholesterol synthesis by fatty acids
Masao, K., & Endo, A. (1977) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(77)90071-6 · Cited by 88
Uauy, R. D., Vega, G. L., Grundy, S. M., & Bilheimer, D. W. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80289-0 · Cited by 86
de Haan, W., van der Hoogt, C. C., Westerterp, M., Hoekstra, M., Dallinga‐Thie, G. M., Princen, H. M. G., Romijn, J. A., Jukema, J. W., Havekes, L. M., & Rensen, P. C. N. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.001 · Cited by 82
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism
Lamon‐Fava, S., Diffenderfer, M. R., Barrett, P. H. R., Buchsbaum, A., Matthan, N. R., Lichtenstein, A. H., Dolnikowski, G. G., Horvath, K. V., Asztalos, B. F., Zago, V., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700067-jlr200 · Cited by 80
Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors
Sirtori, C. R. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90031-8 · Cited by 77
Self-citationClinical response to statins: Mechanism(s) of variable activity and adverse effects
Sirtori, C. R., Mombelli, G. G., Triolo, M., & Laaksonen, R. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.582135 · Cited by 72
Self-citationBallantyne, C. M., Blazing, M. A., Hunninghake, D. B., Davidson, M. H., Yuan, Ž., DeLucca, P. T., Ramsey, K. E., Hustad, C. M., & Palmisano, J. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00440-x · Cited by 72
Hippisley‐Cox, J., & Coupland, C. A. C. (2010) · Heart · doi:10.1136/hrt.2010.199034 · Cited by 71
Fears, R., Richards, D., & FERRES, H. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90185-9 · Cited by 70
Agarwal, R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000143720.71748.79 · Cited by 69
Pierno, S., Didonna, M. P., Cippone, V., Luca, A. D., Pisoni, M., Frigeri, A., Nicchia, G. P., Svelto, M., Chiesa, G., Sirtori, C. R., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706917 · Cited by 67
Self-citationInhibitor of proliferation of arterial smooth-muscle cells by fluvastatin
Corsini, A., Pazzucconi, F., Pfister, P., Paoletti, R., & SIRTORI, C. (1996) · The Lancet · doi:10.1016/s0140-6736(05)66196-x · Cited by 67
Self-citationTanzawa, K., & Akira, E. N. D. O. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb13177.x · Cited by 61
Hogue, J., Lamarche, B., Deshaies, Y., Tremblay, A. J., Bergeron, J., Gagné, C., & Couture, P. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.008 · Cited by 57
Implications of statin adverse effects in the elderly
Golomb, B. A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.3.389 · Cited by 50
Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors
SIRTORI, C. (1990) · Pharmacological Research · doi:10.1016/s1043-6618(05)80047-7 · Cited by 48
Self-citationNaples, M., Federico, L. M., Xu, E., Nelken, J., & Adeli, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.003 · Cited by 48
Chan, D. C., Watts, G. F., Barrett, P. H. R., Martins, I. J., James, A. P., Mamo, J. C. L., Mori, T. A., & Redgrave, T. G. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30112-7 · Cited by 44
Coenzyme Q10 and Statin Myalgia: What is the Evidence?
Mas, E., & Mori, T. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0134-3 · Cited by 43
RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
Medina, M. W., Theusch, E., Naidoo, D., Bauzon, F., Stevens, K., Mangravite, L. M., Kuang, Y.-L., & Krauss, R. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003058 · Cited by 41
A tribute to Akira Endo, discoverer of a “Penicillin” for cholesterol
Brown, M. S., & Goldstein, J. L. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.007 · Cited by 41
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., Nestel, P. J., & Watts, G. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.004 · Cited by 39
Summers, M. J., Oliver, K. R., Coombes, J. S., & Fassett, R. G. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.183 · Cited by 38
Long-term use of statins reduces the risk of hospitalization for dementia
Corrao, G., Ibrahim, B., Nicotra, F., Zambon, A., Merlino, L. G., Pasini, T. S., Catapano, A. L., & Mancia, G. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.009 · Cited by 37
Miettinen, T., & GYLLING, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00106-0 · Cited by 34
Marchesi, M., Parolini, C., Caligari, S., Gilio, D., Manzini, S., Busnelli, M., Cinquanta, P., Camera, M., Brambilla, M., Sirtori, C. R., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01429.x · Cited by 28
Self-citationDiscordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb
Cenedella, R. J., Kuszak, J. R., Al-Ghoul, K. J., Qin, S., & Sexton, P. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200002-jlr200 · Cited by 27
Alternate-day Dosing with Statins
Marcus, G. M., Baumgarten, A. J., Fritz, W. L., & Nolan, P. E. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.08.007 · Cited by 23
3‐hydroxy 3‐methylglutaryl coenzyme A reductase increase is essential for rat muscle differentiation
Martini, C., Trapani, L., Narciso, L., Marino, M., Trentalance, A., & Pallottini, V. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21810 · Cited by 21
Drugs inhibiting HMG-CoA reductase
Endo, A. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90025-7 · Cited by 17
Case–control study of statin prevention of mould infections
Thompson, J. N., Huycke, M. M., Greenfield, R. A., Kurdgelashvili, G., & Gentry, C. A. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01957.x · Cited by 14
Balancing Randomized Trials With Anecdote
Phillips, P. S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00014 · Cited by 6
Cited by
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 407
Mach, F., Ray, K. K., Wiklund, O., Corsini, A., Catapano, A. L., Bruckert, E., De Backer, G., Hegele, R. A., Hovingh, G. K., Jacobson, T. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy182 · Cited by 370
Metadata
- Authors
- Sirtori, C. R.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 88
- Pages
- 3-11
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2039944972
- Cited by
- 691
- References
- 90
- FWCI
- 24.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.